NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 20 filers reported holding NOVUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 3,183,314 | $54,435,000 | 0.68% |
| Asymmetry Capital Management, L.P. | 1,088,907 | $1,034,000 | 0.66% |
| BVF INC/IL | 3,515,873 | $3,340,000 | 0.18% |
| Renaissance Technologies | 758,149 | $720,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 170,176 | $162,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 20,282 | $19,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 11,000 | $10,000 | 0.00% |
| ROYAL BANK OF CANADA | 1 | $0 | 0.00% |
| UBS Group AG | 4,200 | $4,000 | 0.00% |
| THRIVENT FINANCIAL FOR LUTHERANS | 45,761 | $43,000 | 0.00% |